Julie Royle chats with Iain Armstrong, chair of PHA UK, about IV and nebulised therapy, and compares the two for anyone who has a decision to make. She is joined by partner Kevin.
We are appreciative to Johnson & Johnson for an unrestricted grant to support the structure of this website. Johnson & Johnson have had no input into the contents of the website, which remains copyright to the PHA UK.